NO314260B1 - Pyrazol-derivater og antitumormiddel - Google Patents

Pyrazol-derivater og antitumormiddel Download PDF

Info

Publication number
NO314260B1
NO314260B1 NO19993628A NO993628A NO314260B1 NO 314260 B1 NO314260 B1 NO 314260B1 NO 19993628 A NO19993628 A NO 19993628A NO 993628 A NO993628 A NO 993628A NO 314260 B1 NO314260 B1 NO 314260B1
Authority
NO
Norway
Prior art keywords
group
compound
methyl
nmr
added
Prior art date
Application number
NO19993628A
Other languages
English (en)
Norwegian (no)
Other versions
NO993628D0 (no
NO993628L (no
Inventor
Akio Ejima
Satoru Ohsuki
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of NO993628D0 publication Critical patent/NO993628D0/no
Publication of NO993628L publication Critical patent/NO993628L/no
Publication of NO314260B1 publication Critical patent/NO314260B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO19993628A 1997-01-27 1999-07-26 Pyrazol-derivater og antitumormiddel NO314260B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1211697 1997-01-27
PCT/JP1998/000300 WO1998032739A1 (fr) 1997-01-27 1998-01-26 Derives de pirazole

Publications (3)

Publication Number Publication Date
NO993628D0 NO993628D0 (no) 1999-07-26
NO993628L NO993628L (no) 1999-09-22
NO314260B1 true NO314260B1 (no) 2003-02-24

Family

ID=11796592

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19993628A NO314260B1 (no) 1997-01-27 1999-07-26 Pyrazol-derivater og antitumormiddel

Country Status (10)

Country Link
EP (1) EP1022270A4 (fr)
KR (1) KR20000070523A (fr)
CN (1) CN1105707C (fr)
AU (1) AU724394B2 (fr)
CA (1) CA2278677A1 (fr)
EA (1) EA002101B1 (fr)
ID (1) ID22017A (fr)
NO (1) NO314260B1 (fr)
TW (1) TW486478B (fr)
WO (1) WO1998032739A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6169086B1 (en) 1997-01-27 2001-01-02 Daiichi Pharmaceutical Co., Ltd. Pyrazole derivatives
WO2000005230A1 (fr) * 1998-07-24 2000-02-03 Daiichi Pharmaceutical Co., Ltd. Derives de pyrazole et sels correspondants
EP2266973A1 (fr) 2009-05-29 2010-12-29 Bayer CropScience AG Pyrazinylpyrazole
EP2499130A1 (fr) 2009-11-11 2012-09-19 Bayer CropScience AG Nouveaux composés diazinyle-pyrazolyle
KR101663637B1 (ko) * 2009-11-13 2016-10-07 제노스코 키나아제 억제제
CN108430976B (zh) * 2015-12-16 2022-07-05 日本曹达株式会社 芳基唑化合物和有害生物防除剂
TW202120478A (zh) * 2019-11-22 2021-06-01 美商富曼西公司 用於合成(3-氯-2-吡啶基)肼的新穎製程

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3472857A (en) * 1966-02-03 1969-10-14 Ciba Ltd N-(3-pyrazolyl-propyl)-n'-phenyl piperazines
JPS61129129A (ja) * 1984-11-28 1986-06-17 Kureha Chem Ind Co Ltd 抗腫瘍剤
CA1279645C (fr) * 1986-02-27 1991-01-29 Ineke Van Wijngaarden N-piperidinylmethyl-et n-piperazinylmethylazoles a substituant aryle, a proprietes antispychotiques
US4808621A (en) * 1986-07-07 1989-02-28 Warner-Lambert Company Trans-6-[2-(N-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl]- or ethenyl]tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
TW312694B (fr) * 1994-09-26 1997-08-11 Daiichi Seiyaku Co

Also Published As

Publication number Publication date
ID22017A (id) 1999-08-26
CN1251578A (zh) 2000-04-26
CA2278677A1 (fr) 1998-07-30
TW486478B (en) 2002-05-11
EA002101B1 (ru) 2001-12-24
KR20000070523A (ko) 2000-11-25
CN1105707C (zh) 2003-04-16
AU724394B2 (en) 2000-09-21
NO993628D0 (no) 1999-07-26
EP1022270A1 (fr) 2000-07-26
EP1022270A4 (fr) 2002-01-30
NO993628L (no) 1999-09-22
EA199900600A1 (ru) 2000-04-24
WO1998032739A1 (fr) 1998-07-30
AU5577198A (en) 1998-08-18

Similar Documents

Publication Publication Date Title
CA2241787C (fr) Composes aza- et diazacycloheptane et -cyclo-octane substitues et leur utilisation
DK2091918T3 (en) Compounds and Compositions as Protein Kinase Inhibitors
CA2490907C (fr) Derive d'amide
KR100848067B1 (ko) 아미드 유도체 및 의약
JP2008528622A (ja) β−セクレターゼのインヒビターとしてのアミノピリジン
US7906533B2 (en) Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
SK282708B6 (sk) Derivát piperazínu so selektivitou pre D-4 receptor, spôsob jeho prípravy, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje
US6552018B1 (en) Pyrazole derivatives
CS203970B2 (en) Method of producing novel heterocyclyl-oxy-hydroxy-amino-propanes
NZ238624A (en) Pyridine derivatives, compositions, preparations and use thereof
CA2547080A1 (fr) Inhibiteurs heterocycliques de proteine kinase et leurs utilisations
UA71535C2 (en) Corticotropine-releasing antagonists factor, methods for the preparation thereof, pharmaceuitical composition and a method for the treatment
AU2005300733A1 (en) Novel anthranilamide pyridinureas as VEGF receptor kinase inhibitors
CA2000437A1 (fr) Derives de 2-azetidinone
EP1807416B1 (fr) Nicotinamide-pyridine-urées utiles comme inhibiteurs de kinase dans le récepteur du facteur de croissance de l'endothélium vasculaire (VEGF)
JP2002530400A (ja) インテグリン阻害剤としてのプロパン酸誘導体
AU2002325221B2 (en) Pyrazole Derivatives as HIV Reverse Transcriptase Inhibitors
DE69716901T2 (de) 2,4-diaminopyrimidin-derivate
SK107797A3 (en) 2,6-disubstituted pyridines and 2,4-disubstituted pyrimidines and use thereof, herbicidal agents and methods for inhibiting plants growth
NO314260B1 (no) Pyrazol-derivater og antitumormiddel
TW321639B (fr)
Naito et al. Synthesis and antitumor activity of novel pyrimidinyl pyrazole derivatives. III. Synthesis and antitumor activity of 3-phenylpiperazinyl-1-trans-propenes
AU2004200420A1 (en) Inhibitor of cyclooxygenase
RU2261862C2 (ru) Замещенные пирролы
WO2015197188A1 (fr) Carboxamides à base de pyrazolyle utilisables comme inhibiteurs de crac

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees